268 related articles for article (PubMed ID: 34418251)
1. Emerging paradigm shift toward proactive topical treatment of psoriasis: A narrative review.
Papp KA; Dhadwal G; Gooderham M; Guenther L; Turchin I; Wiseman M; Yeung J
Dermatol Ther; 2021 Nov; 34(6):e15104. PubMed ID: 34418251
[TBL] [Abstract][Full Text] [Related]
2. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
Gorgievska Sukarovska B; Lipozencić J
Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
[TBL] [Abstract][Full Text] [Related]
3. PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis.
Stein Gold L; Alonso-Llamazares J; Lacour JP; Warren RB; Tyring SK; Kircik L; Yamauchi P; Lebwohl M;
Adv Ther; 2020 Nov; 37(11):4730-4753. PubMed ID: 32965655
[TBL] [Abstract][Full Text] [Related]
4. Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis.
Lebwohl M; Thaçi D; Warren RB
J Eur Acad Dermatol Venereol; 2021 Feb; 35 Suppl 1(Suppl 1):35-41. PubMed ID: 33619776
[TBL] [Abstract][Full Text] [Related]
5. Systematic literature review of long-term efficacy data for topical psoriasis treatments.
Bark C; Brown C; Svangren P
J Dermatolog Treat; 2022 Jun; 33(4):2118-2128. PubMed ID: 33945378
[TBL] [Abstract][Full Text] [Related]
6. Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).
Lebwohl M; Kircik L; Lacour JP; Liljedahl M; Lynde C; Mørch MH; Papp KA; Perrot JL; Gold LS; Takhar A; Thaçi D; Warren RB; Wollenberg A
J Am Acad Dermatol; 2021 May; 84(5):1269-1277. PubMed ID: 32950546
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics and pharmacodynamics of topical non-biological therapies for psoriasis patients.
Lo A; Greenzaid JD; Gantz HY; Chodri K; Feldman SR
Expert Opin Drug Metab Toxicol; 2024 Apr; 20(4):235-248. PubMed ID: 38553411
[TBL] [Abstract][Full Text] [Related]
8. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
Sukarovska BG; Lipozencić J; Vrzogić P
Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG.
Jalili A; Calzavara-Pinton P; Kircik L; Lons-Danic D; Pink A; Tyring S; de la Cueva P; Gooderham M; Segaert S; Nyholm N; Thoning H; Petersen B; Thaçi D
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):60-67. PubMed ID: 34543474
[TBL] [Abstract][Full Text] [Related]
10. Combining Topical Psoriasis Treatment to Enhance Systemic and Phototherapy: A Review of the Literature.
Bagel J; Gold LS
J Drugs Dermatol; 2017 Dec; 16(12):1209-1222. PubMed ID: 29240856
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sites.
Hoegsberg T; Iversen L; Lange MM; Bissonette R; Carvalho AVE; van de Kerkhof PC; Kirby B; Kleyn CE; van der Walt JM; Wu JJ; Lynde CW
J Dermatolog Treat; 2021 Dec; 32(8):916-921. PubMed ID: 31996058
[TBL] [Abstract][Full Text] [Related]
12. Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment.
van der Vleuten CJ; van de Kerkhof PC
Drugs; 2001; 61(11):1593-8. PubMed ID: 11577796
[TBL] [Abstract][Full Text] [Related]
13. Vitamine D analogue-based therapies for psoriasis.
O'Neill JL; Feldman SR
Drugs Today (Barc); 2010 May; 46(5):351-60. PubMed ID: 20517536
[TBL] [Abstract][Full Text] [Related]
14. Topical therapy for psoriasis: a promising future. Focus on JAK and phosphodiesterase-4 inhibitors.
Rafael A; Torres T
Eur J Dermatol; 2016; 26(1):3-8. PubMed ID: 26552963
[TBL] [Abstract][Full Text] [Related]
15. Topical long-term therapy of psoriasis with vitamin D₃ analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice.
Augustin M; Mrowietz U; Bonnekoh B; Rosenbach T; Thaçi D; Reusch M; Ardabili M; Reich K
J Dtsch Dermatol Ges; 2014 Aug; 12(8):667-82. PubMed ID: 25039309
[TBL] [Abstract][Full Text] [Related]
16. Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway.
Maul JT; Anzengruber F; Conrad C; Cozzio A; Häusermann P; Jalili A; Kolios AGA; Laffitte E; Lapointe AK; Mainetti C; Schlapbach C; Trüeb R; Yawalkar N; Dippel M; Navarini AA
Dermatology; 2021; 237(2):166-178. PubMed ID: 33406520
[TBL] [Abstract][Full Text] [Related]
17. Long-term topical management of psoriasis: the road ahead.
Segaert S; Calzavara-Pinton P; de la Cueva P; Jalili A; Lons Danic D; Pink AE; Thaçi D; Gooderham M
J Dermatolog Treat; 2022 Feb; 33(1):111-120. PubMed ID: 32091278
[TBL] [Abstract][Full Text] [Related]
18. Proactive therapy: New perspectives for long-term topical treatment of psoriasis.
Lis-Święty A; Frątczak A
Dermatol Ther; 2022 May; 35(5):e15364. PubMed ID: 35133689
[TBL] [Abstract][Full Text] [Related]
19. Topical treatment of psoriasis.
Laws PM; Young HS
Expert Opin Pharmacother; 2010 Aug; 11(12):1999-2009. PubMed ID: 20569091
[TBL] [Abstract][Full Text] [Related]
20. Topical treatments for chronic plaque psoriasis.
Mason AR; Mason J; Cork M; Dooley G; Hancock H
Cochrane Database Syst Rev; 2013 Mar; (3):CD005028. PubMed ID: 23543539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
